Objective To assess the real-world effectiveness of molnupiravir (MOL) in reducing the need
for hospitalization in at-risk, non-hospitalized patients with confirmed COVID-19. Methods A …

Молнупиравир является противовирусным препаратом с широким спектром активности
в отношении РНК-вирусов. Проведён анализ безопасности молнупиравира в …

There is a clear need for novel antiviral concepts to control SARS-CoV-2 infection. Based on
the promising anti-coronavirus activity observed for a class of 1, 4, 4-trisubstituted …

SARS-CoV-2 is a new coronavirus that has affected the world since 2019. Interstitial
pneumonia is the most common clinical presentation, but additional symptoms have been …

Abstract Treatment of COVID-19 can be categorized into prophylactic treatment, early-stage
treatment, and late-stage treatment. Prophylactic treatment, as either pre or postexposure …

Background & Aims: Molnupiravir is an oral antiviral drug which is used in the treatment of
patients with COVID-19. The purpose of this study was to investigate the effectiveness and …

Per al tractament de la infecció per SARS-CoV-2, es disposa d'alguns assaigs clínics
controlats que permeten realitzar recomanacions basades en l'evidència. Actualment s' …

Background: One of the basic principles for the treatment of COVID-19 patients is the early
initiation of etiotropic therapy. The evidence base for assessment of the efficacy and safety of …

The COVID-19 pandemic has expanded globally and caused serious consequence in both
health system and the economy. MPV is one of two oral antivirals for COVID-19 with mild-to …